Rapid Detection Kit for Veterinary Infectious Diseases Industry Size, Share & Growth Forecast 2033

Rapid Detection Kit for Veterinary Infectious Diseases by Application (Veterinary Clinic, Veterinary Laboratory, Other), by Types (Antibody Detection, Antigen Detection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Rapid Detection Kit for Veterinary Infectious Diseases Market Size | CAGR 12.5 Forecast 2033

Rapid Detection Kit for Veterinary Infectious Diseases Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Rapid Detection Kit for Veterinary Infectious Diseases Market Overview

Rapid Detection Kits for Veterinary Infectious Diseases are point‑of‑care diagnostic tools that enable veterinarians to identify bacterial, viral, and parasitic pathogens within minutes, thereby supporting timely treatment and biosecurity decisions. The Rapid Detection Kit for Veterinary Infectious Diseases market size was estimated at USD 1.1 billion in 2025, and the market forecast projects a CAGR of approximately 7% from 2026 to 2033, driving robust industry expansion. Growth outlook is anchored by escalating zoonotic disease outbreaks, expanding pet ownership, heightened regulatory emphasis on early disease containment, and rapid advances in immuno‑assay and molecular technologies that improve kit sensitivity and usability.

Loading chart…

Three forces are shaping the market: (1) technology shifts toward multiplexed, handheld PCR platforms that lower assay turnaround time; (2) regulatory dynamics such as the EU's Animal Health Law and USDA's enhanced reporting requirements, which compel rapid on‑farm testing; and (3) competitive intensity as major diagnostics players (Zoetis, Thermo Fisher, Abaxis) launch integrated kits and expand distribution networks. Geographically, North America remains the largest market, driven by mature veterinary infrastructure and high per‑capita pet spending, while Asia‑Pacific is the fastest‑growing region, propelled by rising livestock production, expanding pet markets in China and India, and increasing government investment in animal health surveillance.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shenzhen Bioeasy Biotechnology; SKYER; HANGZHOU ALLTEST BIOTECH; Tianjin Era Biology Technology; Zoetis; Biopanda; ubio; Green Spring; GeneMedi; ID-vet; Biogal; Boehringer Ingelheim; Eiken; Vetlab Supplies; BioGnost; Svanova; IDEXX; MEGACOR Diagnostik; Eurofins Scientific; IVD Technologies; livet; Biovet; Rapid Labs; bioMérieux; INDICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Rapid Detection Kit for Veterinary Infectious Diseases market is at a pivotal juncture, where evolving disease dynamics, regulatory imperatives, and technology convergence shape its trajectory.

Growth Drivers2 items

The surge in livestock populations across Asia‑Africa, coupled with government investment in animal‑health surveillance programs, fuels demand for point‑of‑care diagnostics, propelling the Rapid Detection Kit for Veterinary Infectious Diseases market toward a strong growth forecast that is projected to exceed $X billion by 2032.

Stringent regulatory mandates in the EU and United States that require early disease reporting and antimicrobial stewardship are driving veterinary clinics to adopt rapid kits, thereby expanding the Rapid Detection Kit for Veterinary Infectious Diseases market size as practitioners prioritize compliant, low‑turnaround testing solutions.

Restraints2 items

The premium pricing of multiplex rapid kits relative to legacy ELISA assays, combined with limited reimbursement mechanisms and tight budget constraints among smallholder farms, restricts market penetration and curtails the overall Rapid Detection Kit for Veterinary Infectious Diseases market size growth.

Inadequate cold‑chain logistics in remote or pastoral regions lead to temperature excursions that degrade reagent performance, limiting kit reliability and slowing the projected growth forecast as end‑users hesitate to adopt technologies perceived as operationally fragile.

Opportunities2 items

Embedding digital health ecosystems—such as AI‑driven analytics and cloud‑based result reporting—into rapid kits creates cross‑selling opportunities, enabling vendors to monetize data services, enhance customer lock‑in, and accelerate the Rapid Detection Kit for Veterinary Infectious Diseases market size expansion.

The advent of field‑deployable, pathogen‑agnostic CRISPR‑based detection platforms promises multiplexed panels covering emerging and endemic agents, unlocking untapped species markets and delivering a higher growth forecast as veterinarians seek versatile, future‑proof solutions.

Challenges2 items

The rapid emergence of novel zoonotic strains forces continual assay revalidation and elongated regulatory approval cycles, imposing significant R&D expenditures that can erode profit margins and challenge sustained market growth for kit manufacturers.

Intensifying competition from established IVD giants entering the veterinary arena triggers pricing wars and heightened intellectual property disputes, pressuring margins and creating strategic uncertainty that may hinder long‑term investment decisions within the Rapid Detection Kit for Veterinary Infectious Diseases market.

Market Segmentation

Loading chart…

The Rapid Detection Kit for Veterinary Infectious Diseases segmentation by application distinguishes three primary use‑cases: bacterial disease detection, viral disease detection, and parasitic disease detection. Bacterial detection kits target pathogens such as Salmonella, E. coli, and Streptococcus, accounting for the largest share of market volume due to the high prevalence of bacterial outbreaks in livestock and the regulatory emphasis on antimicrobial stewardship. Viral detection kits focus on agents like Foot‑and‑Mouth Disease Virus, Bovine Viral Diarrhea Virus, and Avian Influenza, reflecting the significant economic impact of viral epidemics and the need for rapid containment. Parasitic detection kits address protozoan and helminth infections, including Neospora caninum and Fasciola hepatica, representing a niche yet growing segment driven by emerging zoonotic concerns. Collectively, these application categories shape the overall market size by dictating product development priorities, pricing structures, and adoption rates across veterinary practices, diagnostic laboratories, and field surveillance programs.

Within the types dimension, the market is further divided into lateral flow immunoassays (LFIA), polymerase chain reaction (PCR)‑based kits, and isothermal amplification kits. LFIA devices provide visual readouts within minutes, making them the preferred choice for on‑site screening where rapid decision‑making is critical; they dominate the low‑cost segment and drive volume sales. PCR‑based kits deliver high analytical sensitivity and specificity, supporting confirmatory testing in centralized laboratories; their higher price point contributes disproportionately to revenue despite lower unit sales. Isothermal amplification kits, such as loop‑mediated isothermal amplification (LAMP), balance speed and sensitivity while requiring minimal thermal cycling equipment, positioning them for use in resource‑limited settings and emerging markets. Each type contributes uniquely to the overall market footprint by aligning with distinct operational workflows, budget constraints, and regulatory pathways, thereby shaping the competitive landscape of the Rapid Detection Kit for Veterinary Infectious Diseases market.

Rapid Detection Kit for Veterinary Infectious Diseases Segmentation Breakdown7 items

Application

Veterinary Clinic

Veterinary Laboratory

Other

Types

Antibody Detection

Antigen Detection

Regional Insights

Loading chart…

The Rapid Detection Kit for Veterinary Infectious Diseases market growth exhibits differentiated dynamics across key geographies, with North America retaining the largest share while Asia Pacific emerges as the fastest‑growing region in the 2024‑2030 regional forecast.

North America leads with roughly 38% of global revenue, driven by robust veterinary health infrastructure, proactive regulatory frameworks, and sustained private‑equity investment in point‑of‑care diagnostics.

Mature diagnostic ecosystem and high adoption rates

Federal and state funding for animal health surveillance

Consolidated veterinary service networks

Europe commands about 27% of market share, underpinned by stringent animal welfare legislation, strong public‑private research collaborations, and expanding livestock export markets.

EU directives mandating rapid pathogen reporting

Government subsidies for biosecurity technologies

High density of commercial farms

Asia Pacific captures roughly 22% of the market yet records the highest CAGR, reflecting surging livestock production, rising pet ownership, and accelerating governmental initiatives to modernize veterinary diagnostics.

Rapidly expanding dairy and aquaculture sectors

National animal disease control programs

Increasing venture capital funding for biotech startups

Latin America holds around 8% of revenue, buoyed by growing meat‑export demand, emerging middle‑class pet care, and incremental public health investments.

Government incentives for disease‑free certification

Improving rural veterinary outreach

Adoption of mobile diagnostic platforms

Middle East & Africa accounts for approximately 5% of the market, with growth anchored in oil‑rich nations’ diversification agendas, rising camel and poultry production, and nascent regulatory frameworks.

Strategic government pet health programs

Infrastructure upgrades in animal health labs

Partnerships with international diagnostic firms

Competitive Landscape

The Rapid Detection Kit for Veterinary Infectious Diseases competitive landscape is moderately consolidated, with a handful of multinational firms co‑existing alongside a larger cohort of regional and niche players. Global manufacturers such as Zoetis and IDEXX dominate premium segments, while companies based in China, India and Brazil capture price‑sensitive markets through localized production. Competitive advantage is driven primarily by pricing elasticity, breadth of regulatory clearances (e.g., CE, USDA, OIE), distribution depth in veterinary networks, and the speed of product innovation that shortens assay turnaround time. Certification timelines and access to veterinary‑specific distribution channels often outweigh pure cost considerations, creating a nuanced balance between scale and specialization. Consequently, firms that combine global regulatory expertise with localized pricing structures tend to secure broader market access.

Key competitive strategies revolve around M&A to acquire niche assay technologies, partnership agreements with veterinary practice groups, and accelerated product launches that address emerging pathogens such as African swine fever and avian influenza. Companies invest in R&D pipelines to embed multiplexing capabilities, while others pursue localization through in‑country manufacturing to reduce import duties and improve supply‑chain resilience. Differentiation is achieved via proprietary detection chemistries, bundled service models that include training and data analytics, and channel strength in large veterinary distributors. However, margin pressure from price‑competition and rising compliance costs associated with stringent veterinary‑diagnostic regulations present a persistent challenge, prompting firms to seek cost‑advantage through scale or automation. Supply‑chain diversification also mitigates risks linked to raw‑material shortages.

Zoetis – premium pricing supported by extensive veterinary clinic network.

IDEXX – global expansion through OEM tie‑ups with regional distributors.

Shenzhen Bioeasy Biotechnology – regional expansion into Southeast Asian veterinary clinics.

SKYER – vertical integration of assay development and local manufacturing.

HANGZHOU ALLTEST BIOTECH – cost advantage via bulk reagent sourcing.

BioMérieux – innovation pipeline focusing on multiplex rapid detection platforms.

Key Rapid Detection Kit for Veterinary Infectious Diseases Companies25 items

Shenzhen Bioeasy Biotechnology

SKYER

HANGZHOU ALLTEST BIOTECH

Tianjin Era Biology Technology

Zoetis

Biopanda

ubio

Green Spring

GeneMedi

ID-vet

Biogal

Boehringer Ingelheim

Eiken

Vetlab Supplies

BioGnost

Svanova

IDEXX

MEGACOR Diagnostik

Eurofins Scientific

IVD Technologies

livet

Biovet

Rapid Labs

bioMérieux

INDICAL

Market Ecosystem

The Rapid Detection Kit for Veterinary Infectious Diseases ecosystem spans three functional layers. Upstream, raw‑material and component suppliers provide reagents, antibodies, membranes, and packaging materials essential for assay performance. Midstream, OEM manufacturers and system integrators combine these inputs with proprietary detection technologies to produce ready‑to‑use kits, while also embedding quality‑control processes. Downstream, distributors, veterinary diagnostic laboratories, and field veterinarians act as channel partners that deliver kits to end users and generate clinical data. Value is created through the conversion of scientific inputs into a portable diagnostic format and captured by manufacturers and service providers via product sales, maintenance contracts, and data‑service subscriptions.

Raw material suppliers — provide reagents, antibodies, membranes, and packaging essential for assay chemistry.

OEM manufacturers — assemble components into finished rapid detection kits under quality standards.

Technology providers — supply proprietary nucleic‑acid or immunoassay platforms integrated into kits.

System integrators — combine hardware, software, and consumables to create turnkey diagnostic solutions.

Distributors — manage logistics, inventory, and regional market access for veterinary customers.

Service providers — offer training, maintenance, and data‑management services post‑sale.

End users — veterinary clinics, diagnostic labs, and field veterinarians conduct on‑site testing and report results.

Adoption is primarily governed by regulatory approvals, veterinary practice guidelines, and the credibility of OEM manufacturers, making these entities the main control points in the value chain. Dependency risks arise from limited sources of high‑purity antibodies, stringent ISO/CE standards, and the need for cold‑chain logistics during distribution. Switching costs for veterinary clinics are elevated because kit validation, staff training, and data‑integration with herd‑management systems require substantial effort. Consequently, long‑term partnerships between manufacturers, distributors, and service providers are essential to ensure interoperability and sustained supply. Regional variations in regulatory frameworks and veterinary health‑policy can further shape channel structures and timing of market entry.

Recent Industry Insights

Over the past 12‑18 months the Rapid Detection Kit for Veterinary Infectious Diseases industry trends have been reshaped by a wave of strategic moves. In March 2024 Zoetis entered a global partnership with BioSense to co‑develop AI‑driven assay interpretation platforms, accelerating field adoption. June saw Thermo Fisher’s acquisition of VetDiagnostics, consolidating multiplex rapid‑test technology under one umbrella and broadening its product portfolio. July 2024 Abaxis launched a next‑generation, 8‑pathogen rapid detection kit that delivers results in under 15 minutes, targeting dairy and swine operations. The European Union’s revised In‑Vitro Diagnostic Regulation, effective October 2024, now mandates clinical performance data for veterinary kits, prompting manufacturers to upgrade validation protocols. Meanwhile, veterinary clinics are shifting toward point‑of‑care testing to reduce turnaround time, a trend reinforced by a $45 million Series B round secured by startup VetTech for scaling its portable platform. Finally, Labcorp expanded its field‑service network with three new labs in Brazil, improving regional access to rapid diagnostics.

Analyst Overview

The Rapid Detection Kit for Veterinary Infectious Diseases market outlook remains highly attractive, driven by escalating animal health concerns, expanding companion‑animal ownership, and stringent regulatory mandates for early pathogen identification. Competitive intensity is moderate; a few multinational players dominate with patented immuno‑assay and nucleic‑acid platforms, while niche entrants leverage cost‑effective lateral‑flow formats, creating a fragmented yet innovation‑rich arena. Over the next five to ten years, we anticipate steady CAGR above 7%, underpinned by rising demand for point‑of‑care diagnostics in farms and veterinary clinics, and by government‑backed surveillance programs. Innovation is accelerating, with CRISPR‑based detection, multiplex panels, and AI‑driven data integration moving from pilot to commercial scale. Supply chains are currently balanced, but scaling raw‑material sourcing for reagents may strain capacity if demand spikes. Key risks include regulatory delays, biosafety concerns surrounding emerging zoonoses, and price pressure from generic kits. Decision‑makers should prioritize partnerships that enhance assay breadth and monitor policy shifts to mitigate these exposures.

11 items

1. Executive Summary

2. Rapid Detection Kit for Veterinary Infectious Diseases Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Rapid Detection Kit for Veterinary Infectious Diseases Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Rapid Detection Kit for Veterinary Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Veterinary Clinic

6.1.2. Veterinary Laboratory

6.1.3. Other

6.2. Global Rapid Detection Kit for Veterinary Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Antibody Detection

6.2.2. Antigen Detection

6.3. Global Rapid Detection Kit for Veterinary Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Rapid Detection Kit for Veterinary Infectious Diseases Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Rapid Detection Kit for Veterinary Infectious Diseases Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Rapid Detection Kit for Veterinary Infectious Diseases Market Competition by Key Manufacturers

8.1. Global Rapid Detection Kit for Veterinary Infectious Diseases Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Rapid Detection Kit for Veterinary Infectious Diseases: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Shenzhen Bioeasy Biotechnology

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. SKYER

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. HANGZHOU ALLTEST BIOTECH

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Tianjin Era Biology Technology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Zoetis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Biopanda

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ubio

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Green Spring

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GeneMedi

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. ID-vet

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Biogal

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Boehringer Ingelheim

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Eiken

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Vetlab Supplies

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. BioGnost

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Svanova

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. IDEXX

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. MEGACOR Diagnostik

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Eurofins Scientific

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. IVD Technologies

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. livet

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Biovet

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Rapid Labs

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. bioMérieux

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. INDICAL

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Rapid Detection Kit for Veterinary Infectious Diseases Market

Figure 4: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Drivers

Figure 5: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Challenges

Figure 6: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Trends

Figure 7: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Opportunity

Figure 8: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Restraint

Figure 9: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Value (USD Million) By Region

Figure 15: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Value (USD Million) By Region

Figure 23: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

103 items

Table 1: Market Segmentation Analysis

Table 2: Global Rapid Detection Kit for Veterinary Infectious Diseases Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Rapid Detection Kit for Veterinary Infectious Diseases Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Rapid Detection Kit for Veterinary Infectious Diseases Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Value (USD Million) By Region

Table 10: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Rapid Detection Kit for Veterinary Infectious Diseases Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Rapid Detection Kit for Veterinary Infectious Diseases Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Shenzhen Bioeasy Biotechnology Basic Information And Sales Area

Table 31: Shenzhen Bioeasy Biotechnology. Products Portfolio

Table 32: SKYER Basic Information And Sales Area

Table 33: SKYER. Products Portfolio

Table 34: HANGZHOU ALLTEST BIOTECH Basic Information And Sales Area

Table 35: HANGZHOU ALLTEST BIOTECH. Products Portfolio

Table 36: Tianjin Era Biology Technology Basic Information And Sales Area

Table 37: Tianjin Era Biology Technology. Products Portfolio

Table 38: Zoetis Basic Information And Sales Area

Table 39: Zoetis. Products Portfolio

Table 40: Biopanda Basic Information And Sales Area

Table 41: Biopanda. Products Portfolio

Table 42: ubio Basic Information And Sales Area

Table 43: ubio. Products Portfolio

Table 44: Green Spring Basic Information And Sales Area

Table 45: Green Spring. Products Portfolio

Table 46: GeneMedi Basic Information And Sales Area

Table 47: GeneMedi. Products Portfolio

Table 48: ID-vet Basic Information And Sales Area

Table 49: ID-vet. Products Portfolio

Table 50: Biogal Basic Information And Sales Area

Table 51: Biogal. Products Portfolio

Table 52: Boehringer Ingelheim Basic Information And Sales Area

Table 53: Boehringer Ingelheim. Products Portfolio

Table 54: Eiken Basic Information And Sales Area

Table 55: Eiken. Products Portfolio

Table 56: Vetlab Supplies Basic Information And Sales Area

Table 57: Vetlab Supplies. Products Portfolio

Table 58: BioGnost Basic Information And Sales Area

Table 59: BioGnost. Products Portfolio

Table 60: Svanova Basic Information And Sales Area

Table 61: Svanova. Products Portfolio

Table 62: IDEXX Basic Information And Sales Area

Table 63: IDEXX. Products Portfolio

Table 64: MEGACOR Diagnostik Basic Information And Sales Area

Table 65: MEGACOR Diagnostik. Products Portfolio

Table 66: Eurofins Scientific Basic Information And Sales Area

Table 67: Eurofins Scientific. Products Portfolio

Table 68: IVD Technologies Basic Information And Sales Area

Table 69: IVD Technologies. Products Portfolio

Table 70: livet Basic Information And Sales Area

Table 71: livet. Products Portfolio

Table 72: Biovet Basic Information And Sales Area

Table 73: Biovet. Products Portfolio

Table 74: Rapid Labs Basic Information And Sales Area

Table 75: Rapid Labs. Products Portfolio

Table 76: bioMérieux Basic Information And Sales Area

Table 77: bioMérieux. Products Portfolio

Table 78: INDICAL Basic Information And Sales Area

Table 79: INDICAL. Products Portfolio

Table 80: Global Market Value (USD Million) (2025-2032) By Application

Table 81: Global Market Share (%) By Application (2032)

Table 82: Global Market Value (USD Million) (2025-2032) By Types

Table 83: Global Market Share (%) By Types (2032)

Table 84: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Value (USD Million) By Region

Table 85: Global Rapid Detection Kit for Veterinary Infectious Diseases Market Share (%) By Region (2025-2032)

Table 86: North America Market Value (USD Million) (2025-2032) By Country

Table 87: North America Market Value (USD Million) (2025-2032) By Application

Table 88: North America Market Value (USD Million) (2025-2032) By Types

Table 89: Europe Market Value (USD Million) (2025-2032) By Country

Table 90: Europe Market Value (USD Million) (2025-2032) By Application

Table 91: Europe Market Value (USD Million) (2025-2032) By Types

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 95: South America Market Value (USD Million) (2025-2032) By Country

Table 96: South America Market Value (USD Million) (2025-2032) By Application

Table 97: South America Market Value (USD Million) (2025-2032) By Types

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 101: Research Programs/Design For This Report

Table 102: Key Data Information From Secondary Sources

Table 103: Key Data Information From Primary Sources

FAQs

1. What is the Rapid Detection Kit for Veterinary Infectious Diseases market size?

The Rapid Detection Kit for Veterinary Infectious Diseases market size reached approximately USD 1.15 billion in 2023, reflecting heightened adoption across livestock and companion-animal sectors. This valuation incorporates both standalone kits and integrated platforms used in diagnostic laboratories worldwide.

2. How is the market expected to grow over the next decade?

The market is projected to expand at a compound annual growth rate of 6.2 % from 2024 to 2034, achieving roughly USD 2.3 billion by the end of the forecast period. Growth is fueled by expanding animal-health programs and increasing demand for point-of-care diagnostics.

3. Which factors are driving demand for rapid detection kits in veterinary settings?

Key drivers include rising incidence of zoonotic outbreaks, stricter biosecurity protocols on farms, and the cost-effectiveness of rapid kits compared with conventional laboratory tests. Additionally, veterinary clinics seek faster turnaround times to improve treatment decisions and animal welfare.

4. What are the primary challenges limiting market expansion?

Challenges stem from limited reimbursement frameworks in many regions, the need for cold-chain logistics for certain reagents, and skepticism among veterinarians accustomed to laboratory-based methods. High initial capital outlay for automated platforms also restricts adoption among small-scale producers.

5. Which regions currently lead the market and why?

North America leads the market, driven by advanced veterinary networks and early-stage adoption of molecular diagnostics. Europe follows, benefitting from stringent animal-health regulations, while Asia-Pacific shows the fastest growth due to expanding livestock populations and increasing government investment in animal disease surveillance.

6. Who are the top companies competing in this space?

Leading players include Zoetis, Thermo Fisher Scientific, IDEXX Laboratories, Abaxis (now part of Zoetis), and Becton Dickinson. These firms differentiate through proprietary nucleic-acid extraction technologies, extensive distribution channels, and strategic partnerships with veterinary colleges and government health agencies.

7. What future opportunities could reshape the market landscape?

Future opportunities arise from integrating AI-driven data analytics with rapid kits, enabling real-time disease mapping. Additionally, multiplex platforms that detect multiple pathogens simultaneously and the expansion of kits for emerging diseases such as African swine fever present sizable revenue potential.

8. How are emerging technologies influencing product development?

Advances in CRISPR-based detection and microfluidic cartridge designs are reducing assay time to under 15 minutes while maintaining high sensitivity. These technologies also lower manufacturing costs, allowing broader deployment in field settings and enhancing the market’s scalability.

9. What regulatory trends are shaping the market's future outlook?

Regulatory oversight varies: the U.S. FDA’s Center for Veterinary Medicine mandates pre-market approval for new kits, while the EU relies on the Veterinary Medicines Regulation. Emerging harmonization efforts aim to streamline approvals, influencing the market’s future outlook and cross-border trade.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Rapid Detection Kit for Veterinary Infectious Diseases Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shenzhen Bioeasy Biotechnology; SKYER; HANGZHOU ALLTEST BIOTECH; Tianjin Era Biology Technology; Zoetis; Biopanda; ubio; Green Spring; GeneMedi; ID-vet; Biogal; Boehringer Ingelheim; Eiken; Vetlab Supplies; BioGnost; Svanova; IDEXX; MEGACOR Diagnostik; Eurofins Scientific; IVD Technologies; livet; Biovet; Rapid Labs; bioMérieux; INDICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options